| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/07/2004 | US20040197302 Positioning in mammalian body ; solidification when exposured to trigger |
| 10/07/2004 | US20040197282 Method and preparation containing idebenone for protecting human skin |
| 10/07/2004 | US20040197265 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 10/07/2004 | US20040194793 Coated nicotine-containing chewing gum, manufacture and use thereof |
| 10/07/2004 | US20040194338 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 10/07/2004 | CA2520445A1 Induction of differentiation of stem cells, and control of differentiation potency of stem cells |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp |
| 10/06/2004 | EP1464645A1 Indole derivative |
| 10/06/2004 | EP1464640A2 20-Epi-16-ene-25-OH-D3-analogs |
| 10/06/2004 | EP1464636A1 Novel substance having antitumor/anti-inflammatory activity |
| 10/06/2004 | EP1464339A1 Cell migration inhibitor |
| 10/06/2004 | EP1464336A1 Use of tryprostatin A for the reversal of cancer drug resistance |
| 10/06/2004 | EP1464335A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463827A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/06/2004 | EP1463823A2 Methods of increasing endogenous erythropoietin (epo) |
| 10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
| 10/06/2004 | EP1463812A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 10/06/2004 | EP1463806A2 Novel cyclooxygenase variants and methods of use |
| 10/06/2004 | EP1463803A2 Hematopoietic cells from human embryonic stem cells |
| 10/06/2004 | EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells |
| 10/06/2004 | EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 10/06/2004 | EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 10/06/2004 | EP1463758A2 Mammal prolactin variants |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 10/06/2004 | EP1463731A1 Dibenzodiazepine derivates, their preparation and use |
| 10/06/2004 | EP1463730A1 Pyrazoloparidazine derivatives |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463727A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 10/06/2004 | EP1463726A2 Aromatic thioether liver x-receptor modulators |
| 10/06/2004 | EP1463725A1 Process and intermediates for pyridazinone antidiabetic agents |
| 10/06/2004 | EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof |
| 10/06/2004 | EP1463715A1 Novel glucagon antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463510A2 Administration of vasopeptidase inhibitors to reduce pulse pressure |
| 10/06/2004 | EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof |
| 10/06/2004 | EP1463508A1 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction |
| 10/06/2004 | EP1463507A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 10/06/2004 | EP1463506A1 Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1463504A1 Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | EP1463501A1 Cis-imidazolines as mdm2 inhibitors |
| 10/06/2004 | EP1463499A1 Method for treating circadian rhythm disruptions |
| 10/06/2004 | EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases |
| 10/06/2004 | EP1463495A2 Agents and methods for treatment of cancer |
| 10/06/2004 | EP1463493A1 Methods of inducing ovulation-using a non-polypeptide camp level modulator |
| 10/06/2004 | EP1463487A1 Liposomal delivery of vitamin e based compounds |
| 10/06/2004 | EP1463481A2 Methods and compositions for treatment of central nervous system disorders |
| 10/06/2004 | EP1463440A2 Prevention of flap necrosis in plastic surgery |
| 10/06/2004 | EP1463408A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 10/06/2004 | EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 10/06/2004 | EP1379262B1 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 10/06/2004 | EP1318837B1 Method of treating estrogen receptor positive carcinoma |
| 10/06/2004 | EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 10/06/2004 | EP1291349B1 Malto-oligosaccharide derivatives and use thereof |
| 10/06/2004 | EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 10/06/2004 | EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 10/06/2004 | EP1169312B1 Glucokinase activators |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1154993B1 Thioamide derivatives |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1101112B1 Leptin-mediated gene-induction |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1064270B1 Disubstituted pyrazolines and triazolines as factor xa inhibitors |
| 10/06/2004 | EP1032424B9 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 10/06/2004 | EP0980252B1 Therapies for acute renal failure |
| 10/06/2004 | EP0975340B1 Therapeutic inhibitor of vascular smooth muscle cells |
| 10/06/2004 | EP0970070B1 Phthalazines with angiogenesis inhibiting activity |
| 10/06/2004 | EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms |
| 10/06/2004 | EP0808309B1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors |
| 10/06/2004 | EP0706563B1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 10/06/2004 | CN1535312A PUFA polyketide synthase systems and uses thereof |
| 10/06/2004 | CN1535282A Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours |
| 10/06/2004 | CN1535275A Prodrugs of 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
| 10/06/2004 | CN1535274A Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 10/06/2004 | CN1535267A 5-membered heterocycles, preparation and use thereof as medicine |
| 10/06/2004 | CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II |
| 10/06/2004 | CN1535265A Novel crystal of arylethenesulfonamide derivative and process for producing the same |
| 10/06/2004 | CN1535264A Arginine derivatives |
| 10/06/2004 | CN1535168A Controlled release composition and method of producing the same |
| 10/06/2004 | CN1535160A Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 10/06/2004 | CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl} |
| 10/06/2004 | CN1535153A Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation |
| 10/06/2004 | CN1535150A Novel use of 2-[5-(40fluorophenyl)3-pyridylmethylaminomethyl] |
| 10/06/2004 | CN1535144A Pharmaceutical combination comprising either (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic aicd or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl) ethyoxy] phenyl} |
| 10/06/2004 | CN1535143A Use of MGLUR 5 antagonists for treatment of pruritic conditions |
| 10/06/2004 | CN1535139A Atorvastatin hemi-calcium form VII |
| 10/06/2004 | CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent |
| 10/06/2004 | CN1534016A Calcium acceptor active compound |
| 10/06/2004 | CN1533768A Leimaquban solid dispersion, prepation method and oral composition |
| 10/06/2004 | CN1533708A Injure preventing agent for forcedly changing feather and method for forcedly changing feather |
| 10/06/2004 | CN1169824C Polytype gene of MXA protein and application thereof |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/06/2004 | CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases |
| 10/06/2004 | CN1169788C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them |
| 10/06/2004 | CN1169533C Umbilical salves for dropping drug and its preparing process |